This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Ochsner Multi-Organ Transplant Institute Named No. 1 In The Nation For Liver Transplants

NEW ORLEANS, Jan. 28, 2013 /PRNewswire/ -- CareChex, a division of The Delta Group specializing in rating the quality of hospital and physician care, has named the Ochsner Multi-Organ Transplant Institute number one in the country for liver transplants in its 2013 Hospital ratings. This prestigious distinction recognizes Ochsner as the top hospital in the nation out of over 100 hospitals rated for liver transplants.

The CareChex Medical Quality Rating System provides a comprehensive, multi-dimensional analysis of medical quality. It incorporates multiple peer-reviewed methodologies which specifically address key components of the quality of inpatient care. The methods for the clinical category of Liver Transplant encompass the following quality measures:
  • Patient Safety Indicators
  • Mortality Rates
  • Complication Rates

"Receiving this recognition is a true testament to our innovation and dedication to excellence we have instituted since inception," said George Loss, Jr., MD, PhD, FACS, System Chair, Department of Surgery, Chief of Ochsner Multi-Organ Transplant Institute. "Our ability to research new technologies and procedures prepares us to meet the future needs of patients from across the country."

"CareChex allows the public to make informed decisions regarding the quality of medical and surgical care provided by hospitals," said Dr. Thane Forthman, managing principal at The Delta Group. "We are pleased to acknowledge that Ochsner has achieved an exceptionally high level of performance, especially in the area of medical excellence for Liver Transplants. Ochsner is a benchmark that other hospitals should seek to emulate."

Ochsner's comprehensive team consists of transplant surgeons, physicians and support specialists who have performed more than 4,500 liver, pancreas, kidney, heart and lung transplants. In 2012, more than 2,900 patients were referred to Ochsner as potential transplant candidates and 356 of those transplant procedures were performed.

"Our team uses a multi-disciplinary approach across the entire system which contributes to our transplant successes," said Nigel Girgrah, MD, PhD, Head of Hepatology, Medical Director of the Multi-Organ Transplant Institute. "This accolade is further proof that we have the right people and processes in place to provide high quality care for these patients."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.19 0.00%
FB $118.06 0.00%
GOOG $695.70 0.00%
TSLA $222.56 0.00%
YHOO $37.40 3.90%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs